Produkty 4965-97-3

CAS 4965-97-3 występuje w naszej ofercie pod nazwami: Bryodulcosigenin/ 99.24% (existing batch purity), Bryodulcosigenin. Oferty producentów: TargetMol, Biosynth, Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg.

Bryodulcosigenin/ 99.24% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 704,78
Zobacz produkt
Bryodulcosigenin
Biosynth, Chemat
  • opakowanie: 50mg, 25mg, 100mg, 1mg
  • Warianty: 9
od 501,20
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,8S,9R,10R,13R,14S,17R)-17-[(2R)-5,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one (CAS 4965-97-3) to związek chemiczny o wzorze sumarycznym C30H50O4 i masie molowej 474.7 g/mol. Nazwa systematyczna IUPAC: (3S,8S,9R,10R,13R,14S,17R)-17-[(2R)-5,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one. InChIKey: FPMQKXQOBKDVHF-ZGUWQJCPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H50O4
Masa molowa474.7 g/mol
Nazwa IUPAC(3S,8S,9R,10R,13R,14S,17R)-17-[(2R)-5,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one
InChIKeyFPMQKXQOBKDVHF-ZGUWQJCPSA-N
SMILESC[C@H](CCC(C(C)(C)O)O)[C@H]1CC[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3CC[C@@H](C4(C)C)O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Bryodulcosigenin
Powiązane formy tego związku
(3S,8S,9R,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one C30H50O4
Izomery (ten sam wzór sumaryczny)
diundecyl benzene-1,2-dicarboxylate C30H50O4
5-[(1R)-1-[(3R,5R,9R,10R,13S,14S,17S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-2,2-dimethyloxolane-3,4-diol C30H50O4
bis(9-methyldecyl) benzene-1,2-dicarboxylate C30H50O4
diundecyl 3,4,5,6-tetradeuteriobenzene-1,2-dicarboxylate C30H50O4
diundecyl benzene-1,2-dicarboxylate C30H50O4
(3R,4S,4aR,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,4,10-triol C30H50O4
(2Z)-2-[(2R,3S,4S)-4-hydroxy-2-(3-hydroxypropyl)-3-[(3E,5R,7E)-5-hydroxy-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dimethylcyclohexylidene]propanal C30H50O4
(3S,4R,4aR,6aR,6bS,8S,8aS,12aS,14aR,14bR)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,8-diol C30H50O4
(5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C30H50O4
icosyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate C30H50O4
(5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C30H50O4